Capstone Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.33M Sell
18,703
-1,443
-7% -$171K 0.06% 357
2017
Q1
$2.39M Sell
20,146
-920
-4% -$104K 0.07% 353
2016
Q4
$2.11M Sell
21,066
-981
-4% -$105K 0.06% 374
2016
Q3
$2.78M Buy
22,047
+1,112
+5% +$137K 0.08% 301
2016
Q2
$2.45M Buy
20,935
+1,492
+8% +$169K 0.07% 321
2016
Q1
$2.01M Buy
19,443
+896
+5% +$86.7K 0.06% 392
2015
Q4
$1.85M Buy
18,547
+1,589
+9% +$155K 0.05% 421
2015
Q3
$1.55M Buy
16,958
+154
+0.9% +$15.4K 0.05% 437
2015
Q2
$1.78M Buy
16,804
+1,699
+11% +$188K 0.05% 411
2015
Q1
$1.72M Buy
15,105
+1,339
+10% +$153K 0.05% 446
2014
Q4
$1.52M Buy
13,766
+608
+5% +$64.1K 0.04% 467
2014
Q3
$1.28M Buy
13,158
+298
+2% +$29.3K 0.04% 474
2014
Q2
$1.3M Sell
12,860
-3,188
-20% -$311K 0.04% 491
2014
Q1
$1.47M Sell
16,048
-2,236
-12% -$206K 0.05% 447
2013
Q4
$1.65M Sell
18,284
-8,449
-32% -$731K 0.05% 432
2013
Q3
$2.13M Buy
26,733
+207
+0.8% +$16.3K 0.05% 423
2013
Q2
$1.93M Buy
+26,526
New +$1.98M 0.05% 431

Other funds holding ZBH

Capstone Asset Management's ZBH Position: Q2 2017 in Review

Capstone Asset Management reduced its Zimmer Biomet (ZBH) stake by 7.2% in Q2 2017, selling an estimated $171K and leaving 18,703 shares worth $2.33M. The position accounts for 0.06% of the portfolio, ranked #357.

Capstone Asset Management first reported a position in ZBH in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.78M in Q3 2016. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Capstone Asset Management held 18,703 shares of Zimmer Biomet worth $2.33M as of Q2 2017.
  • Capstone Asset Management sold 1,443 Zimmer Biomet shares in Q2 2017, an estimated $171K.
  • Zimmer Biomet made up 0.06% of Capstone Asset Management's portfolio in Q2 2017, its #357 holding.
  • Capstone Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Zimmer Biomet position peaked at $2.78M in Q3 2016.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.